Protein C News and Research

RSS

TMPRSS2 protein, a novel target for SARS-CoV-2 drugs

A new study reports the activity of a compound which inhibited TMPRSS2, ultimately preventing severe COVID-19.

28 Jul 2022

Predicting viral antibody escape using pre-pandemic data

A new study reports early prediction of SARS-CoV-2 immune evasion using EVEscape.

28 Jul 2022

Cross-reactive SARS-CoV-2 antibodies after exposure to avian coronavirus vaccine

Researchers identify SARS-CoV-2 cross-reactive antibodies in poultry farm workers exposed to the avian infectious bronchitis virus.

28 Jul 2022

Less than half of Genevans have antibodies neutralizing Omicron sub-variants, study shows

A study by the Geneva University Hospitals (HUG), the Faculty of Medicine of the University of Geneva and the EPFL shows that almost all Genevans (93.8%) have antibodies against SARS-CoV 2, almost three quarters of whom acquired them through an infection.

28 Jul 2022

Newly developed nanobody can get through tough brain cells and treat Parkinson’s disease

Proteins called antibodies help the immune system find and attack foreign pathogens. Mini versions of antibodies, called nanobodies - natural compounds in the blood of animals such as llamas and sharks - are being studied to treat autoimmune diseases and cancer.

28 Jul 2022

Novel targeted therapy may be an effective treatment option for neuroblastoma

New research from VCU Massey Cancer Center - published Thursday in Cell Reports - demonstrated that a novel targeted therapy could be an effective treatment option for a deadly pediatric cancer known as neuroblastoma.

28 Jul 2022

The identification and characterization of an anti-SARS-CoV-2 monoclonal antibody with superior breadth and potency

A recent study published in Nature Microbiology identified a monoclonal antibody neutralizing SARS-CoV-2 Omicron variants.

28 Jul 2022

Does vaccine- or infection-induced immunity protect less well against infection by specific SARS-CoV-2 variants?

Researchers found that vaccinated people were at an increased risk of infection with SARS-CoV-2 Beta, Gamma, or Delta variants.

28 Jul 2022

COVID-19 Moderna vaccine induces significant antibody reactions among children

Researchers illustrated that SARS-CoV-2 messenger ribonucleic acid vaccination triggers potent antibody reactions in children.

28 Jul 2022

The effects of CBD in the treatment of COVID-19–related inflammatory symptoms

Researchers reviewed the effectiveness of cannabidiol in treating COVID-19 inflammatory-related symptoms.

28 Jul 2022

Mesoporous silica nanoparticles: Possibilities in therapeutic development

In this interview, News-Medical talks to Philippe Riviere, Senior Scientist at NanoComposix (now a Fortis Life Sciences company) about mesoporous silica nanoparticles and the possibilities and opportunities they provide to drug delivery, vaccine development and more.

From nanoComposix 28 Jul 2022

Genetic information from bats may help prevent and manage future pandemics, suggests study

Why are bats often linked to incubating coronaviruses such as those behind COVID-19, SARS and other highly contagious respiratory diseases?

28 Jul 2022

New COVID vaccine patch could better fight variants than a traditional needle, finds study

A needle-free vaccine patch could better fight COVID-19 variants, such as Omicron and Delta, than a traditional needle vaccine according to a University of Queensland study in mice.

28 Jul 2022

People who eat more ultra-processed foods may have higher risk of dementia

People who eat the highest amounts of ultra-processed foods like soft drinks, chips and cookies may have a higher risk of developing dementia than those who eat the lowest amounts, according to a new study published in the July 27, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

27 Jul 2022

Gut bacterial 'super-producer' of histamine can cause pain flare-ups in some IBS patients

Researchers from McMaster University and Queen's University have discovered a gut bacterial 'super-producer' of histamine that can cause pain flare-ups in some patients with irritable bowel syndrome (IBS).

27 Jul 2022

Efficacy of COVID mRNA vaccines among patients on CAR‐T‐lymphocyte therapy

Researchers evaluate the effectiveness of mRNA COVID-19 vaccines among patients receiving CAR‐T‐lymphocyte therapy.

27 Jul 2022

Efficacy of monoclonal antibodies against Omicron BA.1, BA.2, and BA.5

Researchers evaluate the neutralizing potency of therapeutic monoclonal antibodies against three sub-lineages of the SARS-CoV-2 Omicron variant.

27 Jul 2022

Incorporating a coronavirus antigen into MMR vaccine to produce COVID-19 immunity in kids

New research has advanced COVID-19 vaccine work in several ways: using a modified live attenuated mumps virus for delivery, showing that a more stable coronavirus spike protein stimulates a stronger immune response, and suggesting a dose up the nose has an advantage over a shot.

27 Jul 2022

Researchers unravel how one gut bacterium influences immunity

From immunity to metabolism to mental health, it seems like the gut microbiome has been linked to every aspect of human health and disease.

27 Jul 2022

A comparison of SARS-CoV-2 antibody profiles in elderly and younger individuals

Researchers evaluate antibody titers after double COVID-19 vaccination among very elderly individuals over the age of 90 and a younger population.

27 Jul 2022

Protein C News and Research

TMPRSS2 protein, a novel target for SARS-CoV-2 drugs

Predicting viral antibody escape using pre-pandemic data

Cross-reactive SARS-CoV-2 antibodies after exposure to avian coronavirus vaccine

Less than half of Genevans have antibodies neutralizing Omicron sub-variants, study shows

Newly developed nanobody can get through tough brain cells and treat Parkinson’s disease

Novel targeted therapy may be an effective treatment option for neuroblastoma

The identification and characterization of an anti-SARS-CoV-2 monoclonal antibody with superior breadth and potency

Does vaccine- or infection-induced immunity protect less well against infection by specific SARS-CoV-2 variants?

COVID-19 Moderna vaccine induces significant antibody reactions among children

The effects of CBD in the treatment of COVID-19–related inflammatory symptoms

Mesoporous silica nanoparticles: Possibilities in therapeutic development

Genetic information from bats may help prevent and manage future pandemics, suggests study

New COVID vaccine patch could better fight variants than a traditional needle, finds study

People who eat more ultra-processed foods may have higher risk of dementia

Gut bacterial 'super-producer' of histamine can cause pain flare-ups in some IBS patients

Efficacy of COVID mRNA vaccines among patients on CAR‐T‐lymphocyte therapy

Efficacy of monoclonal antibodies against Omicron BA.1, BA.2, and BA.5

Incorporating a coronavirus antigen into MMR vaccine to produce COVID-19 immunity in kids

Researchers unravel how one gut bacterium influences immunity

A comparison of SARS-CoV-2 antibody profiles in elderly and younger individuals

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News